1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Zhejiang Ausun Pharmaceutical Co., Ltd.
  6. Summary
    603229   CNE100002XK2

ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD.

(603229)
  Report
End-of-day quote Shanghai Stock Exchange  -  2022-06-28
34.78 CNY   +4.26%
04/19Zhejiang Ausun Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
03/08Zhejiang Ausun Pharmaceutical Co., Ltd. announced that it expects to receive CNY 500 million in funding
CI
03/08Zhejiang Ausun Pharmaceutical Co., Ltd. announced that it expects to receive CNY 500 million in funding
CI
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
06/23/2022 06/24/2022 06/27/2022 06/28/2022 06/29/2022 Date
33.54 34.03 33.34 33.36 34.78 Last
10334410 10735330 11801980 9855488 22381520 Volume
+0.24% +1.46% -2.03% +0.06% +4.26% Change
Estimated financial data (e)
Sales 2022 808 M 121 M 121 M
Net income 2022 219 M 32,7 M 32,7 M
Net Debt 2022 - - -
P/E ratio 2022 64,1x
Yield 2022 0,33%
Sales 2023 1 125 M 168 M 168 M
Net income 2023 313 M 46,7 M 46,7 M
Net Debt 2023 - - -
P/E ratio 2023 44,7x
Yield 2023 0,68%
Capitalization 13 977 M 2 086 M 2 086 M
Capi. / Sales 2022 17,3x
Capi. / Sales 2023 12,4x
Nbr of Employees 846
Free-Float 31,3%
More Financials
Company
Zhejiang Ausun Pharmaceutical Co., Ltd. is a China-based company principally engaged in the research and development, production and sales of specialty bulk pharmaceutical chemicals (BPCs) and pharmaceutical intermediates. The Company's main products include bimatoprost, latanoprost, latanoprostene bunod, entecavir, selectfluor and other intermediates. The Company is also involved in the provision of customized... 
Sector
Pharmaceuticals
Calendar
09/01Earnings Release
More about the company
Ratings of Zhejiang Ausun Pharmaceutical Co., Ltd.
Trading Rating :  -
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD.
04/19Zhejiang Ausun Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter ..
CI
03/08Zhejiang Ausun Pharmaceutical Co., Ltd. announced that it expects to receive CNY 500 mi..
CI
03/08Zhejiang Ausun Pharmaceutical Co., Ltd. announced that it expects to receive CNY 500 mi..
CI
02/23Algernon Pharmaceuticals Inc. Announces Award Contract to Zhejiang Ausun Pharmaceutical..
CI
02/11Chinese Shares End Lower; Pharmaceutical Stlocks Suffer Huge Losses After WuXi Biologic..
MT
2021Ausun Pharma's Shareholder and Party Acting in Concert Plan to Unload 4.91% Stakes
CI
2021Zhejiang Ausun Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months En..
CI
2021MARVEL BIOSCIENCES : up 8.7% as Provides Update on Lead Candidate MB-204 Manufacturing
MT
2021Zhejiang Ausun Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ende..
CI
2021Zhejiang Ausun Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ende..
CI
2021Zhejiang Ausun Pharmaceutical Co., Ltd. Reports Earnings Results for the First quarter ..
CI
2021Zhejiang Qizheng Pharmaceutical Co., Ltd. announced that it has received CNY 50 million..
CI
2021Zhejiang Ausun Pharmaceutical Co., Ltd. Announces Signing Temporary Cooperation Agreeme..
CI
2021Zhejiang Qizheng Pharmaceutical Co., Ltd. announced that it expects to receive CNY 50 m..
CI
2020Zhejiang Ausun Pharmaceutical Co., Ltd. announced that it has received CNY 419.999995 m..
CI
More news
News in other languages on ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD.
04/19Zhejiang Ausun Pharmaceutical Co., Ltd. annonce ses résultats pour le premier trimestre..
02/23Algernon Pharmaceuticals Inc. annonce l'attribution d'un contrat à la société chinoise ..
02/11Les actions chinoises terminent en baisse ; les blocs pharmaceutiques subissent d'énorm..
2021Marvel Biosciences en hausse de 8,7 % après avoir fait le point sur la fabrication de s..
2020Zhejiang Ausun Pharmaceutical Co., Ltd. annonce le dividende en espèces pour 2019, paya..
More news
Chart ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD.
Duration : Period :
Zhejiang Ausun Pharmaceutical Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 34,78
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
Zhi Guo Zheng Chairman & General Manager
Zhen Yu Li Chief Financial Officer & Secretary
Hai Yan Xu Chairman-Supervisory Board
Fu Li Zhang Independent Director
Ming Min Luo Independent Director
Sector and Competitors